Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 16, Issue 10, Pages 1304-1312
Publisher
Oxford University Press (OUP)
Online
2014-04-11
DOI
10.1093/neuonc/nou045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications
- (2014) Van Nguyen et al. Translational Oncology
- Diphtheria toxin-based targeted toxin therapy for brain tumors
- (2013) Yan Michael Li et al. JOURNAL OF NEURO-ONCOLOGY
- Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
- (2013) Christine E. Brown et al. PLoS One
- Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
- (2012) S. Kong et al. CLINICAL CANCER RESEARCH
- Stem-like Tumor-Initiating Cells Isolated from IL13R 2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
- (2012) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele
- (2012) Kenichiro Iwami et al. CYTOTHERAPY
- Recent developments on immunotherapy for brain cancer
- (2012) Derek A Wainwright et al. EXPERT OPINION ON EMERGING DRUGS
- Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2
- (2012) Irina V. Balyasnikova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
- (2012) Jane R. Engler et al. PLoS One
- Specific Targeting of Human Interleukin (IL)-13 Receptor α2-Positive Cells with Lentiviral Vectors Displaying IL-13
- (2012) Wu Ou et al. Human Gene Therapy Methods
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
- (2011) J. N. Kochenderfer et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer
- (2011) Toshio Fujisawa et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing IL-13R 2 Promotes Glioblastoma Cell Death via Endogenous Signaling
- (2011) L. C. Hsi et al. MOLECULAR CANCER THERAPEUTICS
- An interleukin 13 receptor α 2–specific peptide homes to human Glioblastoma multiforme xenografts
- (2011) Hetal Pandya et al. NEURO-ONCOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
- (2010) X. Wang et al. BLOOD
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- A comprehensive outlook on intracerebral therapy of malignant gliomas
- (2010) Carlo Buonerba et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
- (2010) Sabine Mueller et al. JOURNAL OF NEURO-ONCOLOGY
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- Decreasing Expression of the Interleukin-13 Receptor IL-13Rα2 in Treated Recurrent Malignant Gliomas
- (2010) Oliver BOZINOV et al. NEUROLOGIA MEDICO-CHIRURGICA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics
- (2010) M. Candolfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Role of Interleukin-13 Receptor 2 in Pancreatic Cancer Invasion and Metastasis
- (2009) T. Fujisawa et al. CANCER RESEARCH
- Poor drug distribution as a possible explanation for the results of the PRECISE trial
- (2009) John H. Sampson et al. JOURNAL OF NEUROSURGERY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
- (2009) A. B. Madhankumar et al. MOLECULAR CANCER THERAPEUTICS
- A High-Performance Nanobio Photocatalyst for Targeted Brain Cancer Therapy
- (2009) Elena A. Rozhkova et al. NANO LETTERS
- Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction
- (2009) Dong-Hyun Kim et al. NATURE MATERIALS
- Restoration of Tumor Immunosurveillance via Targeting of Interleukin-13 Receptor- 2
- (2008) S. Fichtner-Feigl et al. CANCER RESEARCH
- Second-Generation Anti-Carcinoembryonic Antigen Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor Activity In vivo: A Preclinical Evaluation
- (2008) P. C.R. Emtage et al. CLINICAL CANCER RESEARCH
- Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin
- (2008) T. F. Liu et al. CLINICAL CANCER RESEARCH
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of a human leukocyte antigen-A24–restricted T-cell epitope derived from interleukin-13 receptor α2 chain, a glioma-associated antigen
- (2008) Shinji Shimato et al. JOURNAL OF NEUROSURGERY
- Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin
- (2008) Mitomu Kioi et al. MOLECULAR CANCER THERAPEUTICS
- Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved Specificity
- (2008) Cory Allen et al. MOLECULAR THERAPY
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma
- (2008) Shahriar S Yaghoubi et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started